ACAD Acadia Pharmaceuticals Inc
Pharmaceutical Preparations · Nasdaq · SEC EDGAR official
Market Value*
$2.30B
Revenue (FY)
$1.07B 2025-12-31
Net Income (FY)
$391.00M
P/E (float-based)
5.9
Pharmaceutical company, which developed Nuplazid, based in San Diego, California..